A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer

NCT07707531 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Pancreatic Cancer

Interventions

DRUG: [68Ga]/ [131I]-IR199

Sponsor

Huashan Hospital